CAS 92693-02-2

Fórmula: C20H34O3

InChI: InChI=1S/C20H34O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-5,9,11,14,17,19,21H,2-3,6-8,10,12-13,15-16,18H2,1H3,(H,22,23)/t19-/m0/s1

Chave InChI: IUKXMNDGTWTNTP-IBGZPJMESA-N

SMILES: CCCCC[C@@H](C=CC=CCC=CCCCCCCC(=O)O)O

15(S)-HETRE

CAS: 92693-02-2

15(S)-HETRE is an analog that acts as a kinase inhibitor with potential anti-cancer properties. It has been shown to inhibit the activity of several kinases, including those involved in cancer cell growth and proliferation. Studies have demonstrated its ability to induce apoptosis in Chinese hamster ovary cells and human tumor cells, making it a promising candidate for medicinal use as an anticancer agent. Additionally, 15(S)-HETRE has been found in urine samples of cancer patients, further supporting its potential as a therapeutic protein for cancer treatment.

Fórmula: C₂₀H₃₄O₃

Pureza: Min. 95%

Peso molecular: 322.5 g/mol

Ref: 3D-SDA69302

15(S)-HETrE

CAS: 92693-02-2

15(S)-HETrE, a 15-lipoxygenated DGLA derivative, inhibits human 5-LO with IC50 of 4.6μM; 5% as effective in RBL cells.

Fórmula: C₂₀H₃₄O₃

Cor e Forma: Solid

Peso molecular: 322.48

Ref: TM-T37400